BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 2823715)

  • 1. Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60.
    Inaba M; Okuno S; Nishizawa Y; Yukioka K; Otani S; Matsui-Yuasa I; Morisawa S; DeLuca HF; Morii H
    Arch Biochem Biophys; 1987 Nov; 258(2):421-5. PubMed ID: 2823715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D.
    Honda A; Nakashima N; Mori Y; Katsumata T; Ishizuka S
    J Steroid Biochem Mol Biol; 1992 Jan; 41(1):109-12. PubMed ID: 1310414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA binding property of vitamin D3 receptors associated with 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3.
    Inaba M; Okuno S; Inoue A; Nishizawa Y; Morii H; DeLuca HF
    Arch Biochem Biophys; 1989 Jan; 268(1):35-9. PubMed ID: 2463789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
    Okuno S; Inaba M; Nishizawa Y; Morii H
    Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y; Pike JW; Koeffler HP
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
    Mangelsdorf DJ; Koeffler HP; Donaldson CA; Pike JW; Haussler MR
    J Cell Biol; 1984 Feb; 98(2):391-8. PubMed ID: 6319426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.
    Norman AW; Okamura WH; Farach-Carson MC; Allewaert K; Branisteanu D; Nemere I; Muralidharan KR; Bouillon R
    J Biol Chem; 1993 Jul; 268(19):13811-9. PubMed ID: 8390978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a highly potent fluoro analog of 1,25-dihydroxyvitamin D3 on human bone-derived cells.
    Kiriyama T; Okamoto S; Ejima E; Kurihara N; Hakeda Y; Ito N; Izumi M; Kumegawa M; Nagataki S
    Endocrinology; 1991 Jan; 128(1):81-6. PubMed ID: 1846118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
    Wilhelm F; Mayer E; Norman AW
    Arch Biochem Biophys; 1984 Sep; 233(2):322-9. PubMed ID: 6091549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of 1 alpha,25-dihydroxyvitamin D3 metabolism by introduction of 26,26,26,27,27,27-hexafluoro atoms in human promyelocytic leukaemia (HL-60) cells: isolation and identification of a novel bioactive metabolite, 26,26,26,27,27,27-hexafluoro-1 alpha,23(S),25-trihydroxyvitamin D3.
    Honda A; Nakashima N; Shida Y; Mori Y; Nagata A; Ishizuka S
    Biochem J; 1993 Oct; 295 ( Pt 2)(Pt 2):509-16. PubMed ID: 8240250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hexafluoro-1,25-dihydroxyvitamin D3 and sodium butyrate combination on differentiation and proliferation of HL-60 leukemia cells.
    Yoshida M; Tanaka Y; Eguchi T; Ikekawa N; Saijo N
    Anticancer Res; 1992; 12(6B):1947-52. PubMed ID: 1363510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoride substitution of vitamin D analogs at C-26 and C-27: enhancement of activity of 25-hydroxyvitamin D but not of 1,25-dihydroxyvitamin D on bone and intestine in vitro.
    Stern PH; Mavreas T; Tanaka Y; DeLuca HF; Ikekawa N; Kobayashi Y
    J Pharmacol Exp Ther; 1984 Apr; 229(1):9-13. PubMed ID: 6323693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dibutyryl cAMP enhances the effect of 1,25-dihydroxyvitamin D3 on a human promyelocytic leukemia cell, HL-60, at both the receptor and the postreceptor steps.
    Inaba M; Okuno S; Koyama H; Nishizawa Y; Morii H
    Arch Biochem Biophys; 1992 Feb; 293(1):181-6. PubMed ID: 1309983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of vitamin D-responsive gene expression by fluorinated analogs of calcitriol in rat osteoblastic ROB-C26 cells.
    Miyamoto Y; Shinki T; Ohyama Y; Kasama T; Iwasaki H
    J Biochem; 1995 Nov; 118(5):1068-76. PubMed ID: 8749328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24- and 26-homo-1,25-dihydroxyvitamin D3: preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro.
    Ostrem VK; Tanaka Y; Prahl J; DeLuca HF; Ikekawa N
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2610-4. PubMed ID: 3033654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of 25-hydroxyvitamin D3 metabolism in a human promyelocytic leukemia cell line (HL-60): 1,25-dihydroxyvitamin D3 stimulates the synthesis of 24,25-dihydroxyvitamin D3.
    Reichel H; Koeffler HP; Norman AW
    Arch Biochem Biophys; 1986 Nov; 251(1):222-31. PubMed ID: 3024572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
    Miyaura C; Abe E; Suda T; Kuroki T
    Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
    Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
    J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3.
    Inaba M; Okuno S; Nishizawa Y; Imanishi Y; Katsumata T; Sugata I; Morii H
    Biochem Pharmacol; 1993 Jun; 45(11):2331-6. PubMed ID: 8517874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.